Transplant center directory

Tulane University Hospital and Clinic offers related/unrelated allogeneic and autologous transplants to adult patients with diseases including, but not limited to, AML, ALL, CML, CLL, Multiple Myeloma, Hodgkin's/non-Hodgkin's lymphoma, amyloidoisis, aplastic anemia, myelofibrosis, MDS and certain autoimmune diseases.

This center has been performing allogeneic transplants since 1994 and has been an NMDP/Be The Match transplant center since December 2001.

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 32 patients.

The actual 1-year survival of these patients is 71.9%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 61.1% and 89.3%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.